According to our new research study on “Peripheral Vascular Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and End User,” the market is expected to grow from US$ 11,375.13 million in 2021 to US$ 17,679.72 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The report highlights trends prevailing in the market and drivers and hindrances pertaining to the market growth.

The growth of atherosclerotic plaques in arteries that supply blood to organs, limbs, and the head causes peripheral vascular disorders (PVD). Peripheral artery occlusive disease (PAOD), peripheral artery disease (PAD), and peripheral obliterative arteriopathy are all terms used to describe this condition. It includes disorders of the peripheral veins and arteries and diseases of the peripheral and cardiac circulation in the body. inferior vena cava (IVC) filters, angiography catheters, Endovascular Aneurysm Repair (EVAR) stent grafts, hemodynamic flow alteration, and plague modification devices are among the peripheral vascular devices used to treat peripheral arterial or coronary arterial disease, as well as in peripheral endovascular and coronary procedures. These devices are utilized to reduce patient interference while causing the least amount of disruption during the surgical operation.

Request Sample PDF Brochure –  https://www.theinsightpartners.com/sample/TIPRE00002776/

The peripheral vascular devices market is characterized by the presence of various small and big companies. The market players are adopting strategies such as new product launches, geographic expansion, and technological advancements to increase their market share. In December 2021, Terumo Corporation launched the first commercial case of the Aortic Balloon in the US. The device accommodates physicians in expanding the aorta when using TREO and RELAY stent grafts in endovascular aortic repair.

The growth of atherosclerotic plaques in arteries that supply blood to organs, limbs, and the head causes peripheral vascular disorders (PVD). Peripheral artery occlusive disease (PAOD), peripheral artery disease (PAD), and peripheral obliterative arteriopathy are all terms used to describe this condition. It includes disorders of the peripheral veins and arteries, as well as diseases of the peripheral and cardiac circulation in the body. IVC filters, angiography catheters, EVAR stent-grafts, hemodynamic flow alteration, and plague modification devices are among the peripheral vascular devices used to treat peripheral arterial or coronary arterial disease, as well as in peripheral endovascular and coronary procedures. These devices are utilised to reduce patient interference while causing the least amount of disruption during the surgical operation.

Peripheral Vascular Devices Market majorly consists of players:

• Abbott
• Edwards Lifesciences Corporation
• Medtronic
• Teleflex Incorporated
• Boston Scientific Corporation
• BD
• Cook Medical LLC
• Terumo Corporation
• Braun Melsungen AG
• Cardinal Health Inc

Several in organic approaches, such as product launches, and expansion in the peripheral vascular devices, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market. 

The growth of the market is attributed to rising incidence of atherosclerosis, smoking, alcoholism, and obesity, coupled with the increasing prevalence of peripheral artery disease and arterial embolism drive the market growth. However, the high costs and complications associated with embolization procedures hampers the market growth.Market leaders operating in the market have undertaken various organic and inorganic growth strategies.

Peripheral Vascular Devices Market Industry Updates

In Dec-2021       

• Terumo Corporation launched first commercial case of the Aortic Balloon in the United States. The device accommodates physicians in the expansion of the aorta when using TREO and RELAY stent-grafts in endovascular aortic repair.

In Sep-2021       

• Abbott acquired Walk Vascular, LLC to expand peripheral vascular offerings, and incorporate into Abbott's existing endovascular product portfolio. Financial terms of the acquisition were not disclosed by the companies

In Sep-2021       

• Boston Scientific Corporation acquired California based Devoro Medical, Inc to expand its peripheral intervention product portfolio. Boston Scientific has been a strategic investor in Devoro Medical since 2019 and presently holds an equity stake of approximately 16%. As a result, the transaction consists of an upfront payment of approximately USD 269 million for the 84% stake not yet owned and up to USD 67 million upon achievement of certain clinical and regulatory achievement.

Access Full Report @ https://www.theinsightpartners.com/reports/peripheral-vascular-devices-market  

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876